Aktis Oncology, Inc. (AKTS) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.23B and a free-cash-flow yield of -6.3%. Over the most recent reported fiscal year, revenue grew 336.9% and free cash flow per share fell 511.2%.